| Literature DB >> 34184102 |
Johanna E Camara1, Stephen A Wise2,3, Andrew N Hoofnagle4, Emma L Williams5, Graham D Carter5, Julia Jones5, Carolyn Q Burdette1, Grace Hahm1, Federica Nalin1, Adam J Kuszak6, Joyce Merkel6, Ramón A Durazo-Arvizu7, Pierre Lukas8, Étienne Cavalier8, Christian Popp9, Christian Beckert9, Jan Schultess9, Glen Van Slooten10, Carole Tourneur11, Camille Pease11, Ravi Kaul12, Alfredo Villarreal12, Fiona Ivison13, Ralf Fischer14, Jody M W van den Ouweland15, Chung S Ho16, Emmett W K Law16, Jean-Nicolas Simard17, Renaud Gonthier17, Brett Holmquist18, Marcelo Cidade Batista19, Heather Pham20, Alex Bennett20, Sarah Meadows21,22, Lorna Cox21,22, Eugene Jansen23, Dilshad Ahmed Khan24, Kimberly Robyak25, Michael H Creer25, Mark Kilbane26, Patrick J Twomey26, James Freeman27, Neil Parker27, Jinyun Yuan28, Robert Fitzgerald29, Sohail Mushtaq30, Michael W Clarke31, Norma Breen32, Christine Simpson33, Christopher T Sempos6,34.
Abstract
An interlaboratory study was conducted through the Vitamin D Standardization Program (VDSP) to assess commutability of Standard Reference Materials® (SRMs) and proficiency testing/external quality assessment (PT/EQA) samples for determination of serum total 25-hydroxyvitamin D [25(OH)D] using ligand binding assays and liquid chromatography-tandem mass spectrometry (LC-MS/MS). A set of 50 single-donor serum samples were assigned target values for 25-hydroxyvitamin D2 [25(OH)D2] and 25-hydroxyvitamin D3 [25(OH)D3] using reference measurement procedures (RMPs). SRM and PT/EQA samples evaluated included SRM 972a (four levels), SRM 2973, six College of American Pathologists (CAP) Accuracy-Based Vitamin D (ABVD) samples, and nine Vitamin D External Quality Assessment Scheme (DEQAS) samples. Results were received from 28 different laboratories using 20 ligand binding assays and 14 LC-MS/MS methods. Using the test assay results for total serum 25(OH)D (i.e., the sum of 25(OH)D2 and 25(OH)D3) determined for the single-donor samples and the RMP target values, the linear regression and 95% prediction intervals (PIs) were calculated. Using a subset of 42 samples that had concentrations of 25(OH)D2 below 30 nmol/L, one or more of the SRM and PT/EQA samples with high concentrations of 25(OH)D2 were deemed non-commutable using 5 of 11 unique ligand binding assays. SRM 972a (level 4), which has high exogenous concentration of 3-epi-25(OH)D3, was deemed non-commutable for 50% of the LC-MS/MS assays.Entities:
Keywords: 25-Hydroxyvitamin D2; 25-Hydroxyvitamin D3; Ligand binding assay; Liquid chromatography-tandem mass spectrometry (LC-MS/MS); Total 25-hydroxyvitamin D; Vitamin D Standardization Program (VDSP)
Mesh:
Substances:
Year: 2021 PMID: 34184102 PMCID: PMC8431775 DOI: 10.1007/s00216-021-03470-w
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.478